Clinical Trial Update: HC-1119 Adjuvant Treatment for Hospitalized COVID-19 Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for HC-1119 as adjuvant treatment in hospitalized COVID-19 patients; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Infection

Drugs mentioned

• HC-1119

Snippet

Sponsor: Applied Biology, Inc. | Conditions: COVID-19 Respiratory Infection | Phase 3 | Status: UNKNOWN